Literature DB >> 31720871

Growth conditions, physiological properties, and selection of optimal parameters of biodegradation of anticancer drug daunomycin in industrial effluents by Bjerkandera adusta CCBAS930.

Teresa Korniłłowicz-Kowalska1, Kamila Rybczyńska-Tkaczyk2.   

Abstract

The study characterizes the anamorphic Bjerkandera adusta strain CCBAS 930, including growth conditions, physiological properties, and enzymatic activities related to basic metabolism and specific properties coupled with the fungal secondary metabolism. It was established that the fungus grows in a wide pH range (3.5-7.5), up to 3% of salt concentration and a temperature of 5-30 °C. Media rich in natural organic components (potato, maize extracts, whey) are optimal for biomass propagation. Minimal media, containing mineral salts and glucose as well as static growth conditions, are required to obtain idiophasic mycelium, equivalent to the secondary metabolism of the fungus. Of the 7 complex C, N, and energy sources tested, the strain did not utilize only fibrous cellulose. Lipolytic activity reached the highest values of the enzymatic activities corresponding to those capabilities. The specific properties of strain B. adusta CCBAS 930 determined by the production of HRP-like peroxidase were related to the decolorization and biodegradation of anthraquinone derivative daunomycin. The decolorization of 30% of daunomycin effluents occurred most rapidly in iso-osmotic medium and non-enriched with nitrogen, containing 0.25% glucose, pH = 5.0-6.0, and 25-30 °C. In agitated cultures, the strain decolorized solutions of daunomycin by biosorption, which coincided with the inhibition of aerial mycelium production and HRP-like biosynthesis. Based on knowledge, potential and real possibilities of using the strain in bioremediation of colored industrial sewage were discussed.

Entities:  

Keywords:  Anamorphic Bjerkandera adusta strain; Biodegradation; Daunomycin; Growth condition; Physiological properties

Year:  2019        PMID: 31720871     DOI: 10.1007/s10123-019-00102-3

Source DB:  PubMed          Journal:  Int Microbiol        ISSN: 1139-6709            Impact factor:   2.479


  3 in total

1.  Possibility to Biotransform Anthracyclines by Peroxidases Produced by Bjerkandera adusta CCBAS 930 with Reduction of Geno- and Cytotoxicity and Pro-Oxidative Activity.

Authors:  Kamila Rybczyńska-Tkaczyk; Teresa Korniłłowicz-Kowalska; Konrad A Szychowski
Journal:  Molecules       Date:  2021-01-17       Impact factor: 4.411

2.  Enhanced Efficiency of the Removal of Cytostatic Anthracycline Drugs Using Immobilized Mycelium of Bjerkandera adusta CCBAS 930.

Authors:  Kamila Rybczyńska-Tkaczyk
Journal:  Molecules       Date:  2021-11-12       Impact factor: 4.411

3.  Intragenomic Variability of ITS Sequences in Bjerkandera adusta.

Authors:  Peter Pristas; Terezia Beck; Maria Piknova; Svetlana Gaperova; Martin Sebesta; Jan Gaper
Journal:  J Fungi (Basel)       Date:  2022-06-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.